Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation

Adult acute lymphoblastic leukemia (ALL) with BCR-ABL1 rearrangement (Philadelphia chromosome, Ph) is a hematological aggressive disease with a fatal outcome in more than 50% of cases. Tyrosine kinase inhibitors (TKIs) targeting the activity of BCR-ABL1 protein have improved the prognosis; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Giudice, Valentina, Ghelli Luserna di Rorà, Andrea, Serio, Bianca, Guariglia, Roberto, Giannini, Maria Benedetta, Ferrari, Anna, Simonetti, Giorgia, Selleri, Carmine, Martinelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765866/
https://www.ncbi.nlm.nih.gov/pubmed/33419251
http://dx.doi.org/10.3390/ijms21249724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765866/
https://www.ncbi.nlm.nih.gov/pubmed/33419251
http://dx.doi.org/10.3390/ijms21249724

Ejemplares similares